Document is current
Any future updates will be listed below
-
Authors
Gorchakov, Andrey A.
Kulemzin, Sergey V.
Guselnikov, Sergey V.
Baranov, Konstantin O.
Belovezhets, Tatyana N.
Mechetina, Ludmila V.
Volkova, Olga Yu.
Najakshin, Alexander M.
Chikaev, Nikolai A.
Chikaev, Anton N.
Solodkov, Pavel P.
Larichev, Victor F.
Gulyaeva, Marina A. https://orcid.org/0000-0003-3945-5339
Markhaev, Alexander G.
Kononova, Yulia V.
Alekseyev, Alexander Yu.
Shestopalov, Alexander M.
Yusubalieva, Gaukhar M.
Klypa, Tatiana V.
Ivanov, Alexander V.
Valuev-Elliston, Vladimir T.
Baklaushev, Vladimir P.
Taranin, Alexander V. https://orcid.org/0000-0002-9184-4238
- License Information
-
More Information
Article History
Received: 16 April 2021
Accepted: 24 September 2021
First Online: 19 October 2021
Conflict of interest
: Patent applications are being filed for the iB series of nAbs. K.O.B., L.V.M., O.Y.V., A.M.N., N.A.C., and A.V.T. are employees of IMGEN+, LLC. This work was funded by IMGEN+, LLC and several grants listed above.
: This study adhered to the human experimentation guidelines as outlined by the Helsinki Declaration of 1975. The collection and analysis of clinical information and biological samples was approved by the Ethics Committee at the FRSC FMBA of Russia, protocol NO. 4_2020 dated April 28, 2020, which also approved all the procedures for obtaining written informed consent from all participants in the study. Two copies of the consent were signed, with one copy provided to the participants and one copy archived at the Federal Research Clinical Center of the Federal Biomedical Agency of Russia (FRCC FMBA of Russia, Moscow). This study was also conducted in accordance with the recommendations of the Animal Research Guidelines of the Committee on Biomedical Ethics of the Federal Research Center for Fundamental and Translational Medicine (Novosibirsk, Russia) and approved by the Committee, protocol no 35 on December 5, 2020.
